Join to View Full Profile
10646 Science Center DrCB10San Diego, CA 92121
Phone+1 858-622-8019
Fax+1 877-481-5208
Dr. Levin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2001 - 2004
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1998 - 2001
St. George's University School of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 2000 - 2027
WA State Medical License 2001 - 2009
Clinical Trials
- ME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors Start of enrollment: 2014 Apr 01
Publications & Presentations
PubMed
- 20 citationsFirst-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.Sarina A Piha-Paul, Binghe Xu, Ecaterina E Dumbrava, Siqing Fu, Daniel D Karp
The Oncologist. 2024-04-04 - 109 citationsPerspectives from man’s best friend: National Academy of Medicine’s Workshop on Comparative OncologyAmy K. LeBlanc, Matthew Breen, Peter L. Choyke, Mark W. Dewhirst, Timothy M. Fan
Science Translational Medicine. 2016-02-03 - 96 citationsTreatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics studyGiovanni Martinelli, Vivian G. Oehler, Cristina Papayannidis, Rachel Courtney, Naveed Shaik
The Lancet. Haematology. 2015-08-01
Press Mentions
New Data Demonstrates Novel Genomic Technology Provides Ultra-Sensitive Detection of Gene Fusions from RNAOctober 18th, 2022- New California Law Increases Access to Biomarker Testing for Late-Stage Cancer PatientsOctober 13th, 2021
- Winning the Race to Fight Lung Cancer? Medtech Company with RTP Lab Says It Can Speed up Biomarker Test at Lower CostsSeptember 8th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
